Press Release

Oct, 31 2023

China Takes the Lead in Asia-Pacific Excipients Market Through Strong Healthcare and Research Prowess

Excipients are essential in pharmaceuticals, serving as inactive ingredients in drug formulations, ensuring stability, solubility, and consistency. Recent advancements have improved excipients, offering controlled drug release and enhancing bioavailability. They are also pivotal in formulating novel drug delivery systems such as nanoparticles and liposomes. These innovations play a crucial role in targeted drug delivery and personalized medicine. Excipients' evolving capabilities are thus vital for pharmaceutical advancements, optimizing drug performance and patient experiences.

Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/asia-pacific-excipients-market

Data Bridge Market Research analyses that the Asia-Pacific Excipients Market, which was USD 1,143.55 million in 2022, is expected to reach USD 1,932.68 million by 2030 and is expected to undergo a CAGR of 8.2% during the forecast period of 2023 to 2030. The expanding nutraceutical sector, driven by increasing consumer interest in health and wellness, fuels the demand for excipients. These inactive ingredients are critical in formulating dietary supplements, ensuring product stability, efficacy, and quality.

Key Findings of the Study

Asia-Pacific Excipients Market

Regulatory compliance is expected to drive the market's growth rate

Stringent quality and safety regulations significantly impact excipient selection in the excipients market. Regulatory bodies enforce strict standards to ensure the safety and efficacy of pharmaceutical and healthcare products. Excipients must comply with these regulations to maintain the integrity of the final drug formulations. As a result, excipient manufacturers are compelled to invest in research and development to create high-quality, compliant ingredients, fostering trust among pharmaceutical companies and ultimately shaping the market's dynamics.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Origin (Organic, Inorganic), Category (Primary Excipients, Secondary Excipients), Products (Polymers, Sugars, Alcohols, Minerals, Gelatin, Others), Chemistry Type (Plant, Animals, Synthetic, Minerals), Chemistry Synthesis (Lactose Monohydrate, Sucralose, Polysorbate, Benzyl Alcohol, Cetosteary Alcohol, Soy Lecithin, Pregelatinized Starch, Others), Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others)

Countries Covered

 China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

Market Players Covered

Ashland Global Holdings Inc. (U.S.), BASF SE (Germany), Croda International Plc (U.K.), Colorcon Inc. (U.S.), Dow (U.S.), Evonik Industries AG (Germany), FMC Corporation (U.S.), Innophos Holdings Inc. (U.S.), JRS Pharma (Germany), Kerry Group plc (Ireland), Shin-Etsu Chemical Co., Ltd. (Japan), Zhejiang Hengdian Apeloa Imp. & Exp. Co., Ltd. (China), Merck KGaA (Germany)

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The Asia-Pacific excipients market is segmented on the basis of origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user, and distribution channel. 

  • On the basis of origin, the Asia-Pacific excipients market is segmented into organic, and inorganic.
  • On the basis of category, the Asia-Pacific excipients market is segmented into primary excipients, and secondary excipients.
  • On the basis of products, the Asia-Pacific excipients market is segmented into polymers, sugars, alcohols, minerals, gelatin, and others.
  • On the basis of chemistry type, the Asia-Pacific excipients market is segmented into plant, animals, synthetic, and minerals.
  • On the basis of chemical synthesis, the Asia-Pacific excipients market is segmented into lactose monohydrate, sucralose, polysorbate, benzyl alcohol, cetosteary alcohol, soy lecithin, pregelatinized starch, and others.
  • On the basis of functionality, the Asia-Pacific excipients market is segmented into binders and adhesives, disintegrants, coating material, coloring agents, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidients, chelating agents, antifoaming agents, and others.
  • On the basis of dosage forms, the Asia-Pacific excipients market is segmented into solid, semi-solid, and liquid.
  • On the basis of route of administration, the Asia-Pacific excipients market is segmented into oral excipients, topical excipients, parenteral excipients, and other excipients.
  • On the basis of end user, the Asia-Pacific excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organization and academics, and others.
  • On the basis of distribution channel, the Asia-Pacific excipients market is segmented into direct tender, retail sales, and others.

Major Players

Data Bridge Market Research recognizes the following companies as the Asia-Pacific excipients market players in Asia-Pacific excipients market are Ashland Global Holdings Inc. (U.S.), BASF SE (Germany), Croda International Plc (U.K.), Colorcon Inc. (U.S.), Dow (U.S.), Evonik Industries AG (Germany), FMC Corporation (U.S.).

Asia-Pacific Excipients Market

Market Developments

  • In December 2022, BASF Pharma Solutions secured FDA approval for its Soluplus excipient, a significant achievement. Soluplus enhances the oral bioavailability and solubility of challenging, poorly soluble active pharmaceutical ingredients. This regulatory green light marks the excipient's role in addressing formulation difficulties, enabling more effective drug development. The approval contributes to the pharmaceutical industry by offering innovative solutions to enhance drug performance and efficacy.
  • In March 2022, CD Formulation introduced custom-tailored solutions designed to enhance the bioavailability of pharmaceuticals. Poor bioavailability has long been a challenge in drug development, impacting the effectiveness of medications. CD Formulation's innovative offerings aim to address this issue by optimizing the delivery of active ingredients, potentially revolutionizing drug formulations and improving their therapeutic impact.

Regional Analysis

Geographically, the countries covered in the Asia-Pacific excipients market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

As per Data Bridge Market Research analysis:

China is the dominant region in Asia-Pacific excipients market during the forecast period 2023-2030

China's dominance in the Asia-Pacific excipients market can be attributed to its robust healthcare infrastructure, the presence of key industry players, and a growing focus on research and development. The country's well-established healthcare facilities create a substantial demand for excipients, and the collaboration between major industry leaders and the increasing research initiatives further solidify China's leading role in this vital pharmaceutical sector.

For more detailed information about the Asia-Pacific excipients market report, click here – https://www.databridgemarketresearch.com/fr/reports/asia-pacific-excipients-market


CHOOSE LICENCE TYPE

  • 7000
  • 4800
  • 3000
  • 8000
  • 12000
Banner

Client Testimonials